Showing results (1961-1970 of 2,112) with videos related to

Sort By:
Pageof 212
Science Immunology|December 12, 2025
Hypoxia-induced EGR1 remodels neutrophils to suppress antitumor immunityTian-Gen Chang, Jay Friedman, Paul E Clavijo, et al.
Neuropathology and Applied Neurobiology|March 16, 2022
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumoursRomain Appay, Franck Bielle, Philipp Sievers, et al.
The Journal of Clinical Investigation|June 21, 2022
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancerJason M Redman, Jay Friedman, Yvette Robbins, et al.
Neuro-Oncology|December 11, 2023
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trialMaximilian Y Deng, Sybren L N Maas, Felix Hinz, et al.
The Journal of Clinical Investigation|April 15, 2026
Peripheral vaccination-induced brain-resident memory CD8+ T cells durably protect mice against intracranial malignancyMadison R Mix, Cassie M Sievers, Mariah Hassert, et al.
AIDS (London, England)|September 17, 2021
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infectionPedro Cahn, Juan Sierra Madero, José R Arribas, et al.
Science Advances|February 4, 2020
Monolithic mtesla-level magnetic induction by self-rolled-up membrane technologyWen Huang, Zhendong Yang, Mark D Kraman, et al.
Journal of Neurochemistry|December 15, 2025
Valproic Acid-Induced Autistic-Like Behavior Is Accompanied by Intestinal Damage Driving Changes in Gut Permeability in a Sex-Dependent Way in RatsBruna Longo, Ruan Kaio Silva Nunes, Camila André Cazarin, et al.
Trials|June 21, 2013
A multi-center study on the regenerative effects of erythropoietin in burn and scalding injuries: study protocol for a randomized controlled trialChristina Irene Günter, Augustinus Bader, Ulf Dornseifer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in GabonGhyslain Mombo-Ngoma, Jonathan Remppis, Moritz Sievers, et al.
Pageof 212